About the Company
maravai lifesciences catalyzes the growth of successful, entrepreneurial life science companies by providing expertise, capital, processes and systems so that they can continue to serve scientists who are striving to improve human health. current maravai lifesciences portfolio companies provide enabling tools and services in the life sciences research and bioproduction industries that accelerate breakthrough discoveries in areas such as genomics, proteomics, and biotherapeutic development. maravai lifesciences was formed in march 2014 through a partnership with gtcr, a leading private equity firm. our mission is to build a transformative life sciences reagents company by acquiring outstanding businesses and accelerating their growth. since our founding, we have acquired four companies, each a leader in its market segment. vector laboratories has led the market for labeling and detection products used by researchers in immunohistochemistry, immunofluorescence and related techniques. tri
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $MRVI News
Should You Sell Maravai LifeSciences (MRVI)?
ClearBridge Mid Cap Strategy featured stocks like Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) in the fourth quarter ...
MRVI Maravai LifeSciences Holdings, Inc.
Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases ...
Q4 2023 Maravai LifeSciences Holdings Inc Earnings Call
Andrew Burch; President of Nucleic Acid Production; Maravai LifeSciences Holdings, Inc. Debra Hart; Senior Director of IR; Maravai LifeSciences Holdings, Inc. Kevin M. Herde; Executive VP & CFO ...
Here’s Why Maravai LifeSciences Holdings Inc (NASDAQ: MRVI) Is An Attractive Investment Right Now
The trading price of Maravai LifeSciences Holdings Inc (NASDAQ:MRVI) closed lower on Tuesday,March 12, closing at $7.74, -0.13% lower than its previous close. In examining the 52-week price action we ...
Maravai LifeSciences Holdings Inc - Ordinary Shares - Class A
Maravai Lifesciences Holdings, Inc. is a life sciences company. It is engaged in providing products to enable the development of drug therapies, diagnostics, and novel vaccines and to support ...
Maravai LifeSciences Holdings Inc (MRVI) Faces Net Loss in 2023 Despite Revenue Outperformance
Warning! GuruFocus has detected 3 Warning Sign with MRVI. On February 22, 2024, Maravai LifeSciences Holdings Inc (NASDAQ:MRVI) released its 8-K filing, detailing the financial results for the ...
Maravai LifeSciences Reports Fourth Quarter and Full Year 2023 Financial Results
SAN DIEGO, Feb. 22, 2024 (GLOBE NEWSWIRE) -- Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech ...
Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Just Released Its Annual Results And Analysts Are Updating Their Estimates
The investors in Maravai LifeSciences Holdings, Inc.'s (NASDAQ:MRVI) will be rubbing their hands together with glee today, after the share price leapt 57% to US$8.36 in the week following its yearly ...
Maravai LifeSciences Holdings Inc Ordinary Shares - Class A
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Maravai Lifesciences Holdings Inc (MRVI)
Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases ...
Loading the latest forecasts...